Caladrius Biosciences, Inc. (CLBS) Social Stream
CALADRIUS BIOSCIENCES INC (CLBS) Price Targets From Analysts
Use the tables below to see what analysts covering CALADRIUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 18 months, CLBS's average price target has gone down $4.5.
Over the past 48 weeks, CLBS's average upside potential has been 932.23%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CLBS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 29 months, CLBS's average broker recommendation rating worsened by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CLBS as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CALADRIUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 393.3% of them.
- CALADRIUS BIOSCIENCES INC's average analyst price target is greater than 27.25% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, CALADRIUS BIOSCIENCES INC's number of analysts covering the stock is higher than 26.38% of them.
- CLBS has a lower variance in analysts' estimates than -40.51% of Healthcare stocks.
Is CLBS a Buy, Hold or Sell? See the POWR Ratings now!